Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Participation in the Food and Drug Administration Commissioner's Fellowship Program, 64805-64806 [2014-25893]

Download as PDF Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices size, use this information to deduce the identity of a particular individual). may make searching for a record easier and prevent delay). RETENTION AND DISPOSAL: RECORD ACCESS PROCEDURE: CMS will retain information for a total period not to exceed 30 years. All claims-related records are encompassed by the document preservation order and will be retained until notification is received from DOJ. An individual seeking access to records about him or her in this system should use the same procedures outlined in Notification Procedures above. The requestor should also reasonably specify the record contents being sought. (These procedures are in accordance with Department regulation 45 CFR 5b.5(a)(2).) RETRIEVING, ACCESSING, RETAINING, AND DISPOSING OF RECORDS IN THE SYSTEM: STORAGE: CONTESTING RECORD PROCEDURES: All records are stored on electronic media. RETRIEVABILITY: The collected data are retrieved by an individual identifier; e.g., beneficiary, recipient or provider name, HICN, or unique provider identification number (NPI). SAFEGUARDS: CMS has safeguards in place for authorized users and monitors such users to ensure against excessive or unauthorized use. Personnel having access to the system have been trained in the Privacy Act and information security requirements. Employees who maintain records in this system are instructed not to release data until the intended recipient agrees to implement appropriate management, operational and technical safeguards sufficient to protect the confidentiality, integrity and availability of the information and information systems and to prevent unauthorized access. This system will conform to all applicable Federal laws and regulations and Federal, HHS, and CMS policies and standards as they relate to information security and data privacy. These laws and regulations may apply but are not limited to: The Privacy Act of 1974; and the Federal Information Department regulation 45 CFR 5b.7. SYSTEM MANAGER AND ADDRESS: Director, Data Development and Services Group, Office of Information Products and Data Analytics (OIPDA), OEM, Mail Stop B2–29–04, CMS, 7500 Security Boulevard, Baltimore, MD 21244–1849. asabaliauskas on DSK5VPTVN1PROD with NOTICES NOTIFICATION PROCEDURE: An individual record subject who wishes to know if this system contains records about him or her should write to the system manager who will require the system name, HICN, and for verification purposes, the subject individual’s name (woman’s maiden name, if applicable), and SSN (furnishing the SSN is voluntary, but it VerDate Sep<11>2014 18:51 Oct 30, 2014 Jkt 235001 To contest a record, the subject individual should contact the system manager named above, and reasonably identify the record and specify the information to be contested. The individual should state the corrective action sought and the reasons for the correction with supporting justification. (These procedures are in accordance with Department regulation 45 CFR 5b.7.) RECORDS SOURCE CATEGORIES: Frm 00065 Fmt 4703 Sfmt 4703 and Assessment Information Set, System No. 09–70–0522 (72 FR 63906 (November 13, 2007)); and Integrated Data Repository, System No. 09–70– 0571 (71 FR 74915 (December 13, 2006)); Provider Enrollment Chain and Ownership System, System No. 09–70– 0532 (71 FR 60536 (October 13, 2006); Medicare and Medicaid Electronic Health Record (EHR) Incentive Program National Level Repository, System No. 09–70–0587 (75 FR 73095 (November 29, 2010)); Performance Measurement and Reporting System, System No. 09– 70–0584 (74 FR 17672 (April 16, 2009)); Encounter Data System, 09–70–0506 (79 FR 34539 (June 17, 2014)); and National Death Index, 09–20–0166 (49 FR 37692 (September 25, 1984)). SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS OF THE ACT: None. Celeste Dade-Vinson, Health Insurance Specialist, Centers for Medicare & Medicaid Services. [FR Doc. 2014–25937 Filed 10–30–14; 8:45 am] The data collected and maintained in this system are retrieved from the following databases: Medicare Drug Data Processing System, System No. 09– 70–0553 (73 FR 30943 (May 29, 2008)); Medicare Beneficiary Database, System No. 09–70–0536 (71 FR 70396 (December 4, 2006)); Medicare Advantage Prescription Drug System, System No. 09–70–0588 (76 FR 47190 (August 4, 2011)); Medicaid Statistical Information System, System No. 09–70– 0541 (71 FR 65527 (November 8, 2006)); Retiree Drug Subsidy Program, System No. 09–70–0550 (70 FR 41035 (July 15, 2005)); Common Working File, System No. 09–70–0526 (71 FR 64955 (November 6, 2006)); National Claims History, System No. 09–70–0558 (71 FR 67137 11/20/2006 (November 20, 2006)); Enrollment Database, System No. 09–70–0502 (73 FR 10249 2/26/ 2008 (February 26, 2008)); Carrier Medicare Claims Record, System No. 09–70–0501 (71 FR 64968 11/6/2006 (November 6, 2006)); Intermediary Medicare Claims Record, System No. 09–70–0503 (71 FR 648961 (November 6, 2006)); Unique Physician/Provider Identification Number, System No. 09– 70–0525 (71 FR 66535 (November 15, 2006)); Medicare Supplier Identification File, System No. 09–70–0530 (71 FR 70404 (December 4, 2006)), A Current Beneficiary Survey, System No. 09–70– 0519 (71 FR 60722 (October 16, 2006)); National Plan & Provider Enumerator System, System No. 09–70–0555, (75 FR 30411 (June 1, 2010)); Long Term Care MDS, System No. 09–70–0528 (72 FR 12801 (March 19, 2007)); HHA Outcome PO 00000 64805 BILLING CODE 4120–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–1072] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Participation in the Food and Drug Administration Commissioner’s Fellowship Program AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by December 1, 2014. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or emailed to oira_ submission@omb.eop.gov. All comments should be identified with the OMB control number 0910—New and SUMMARY: E:\FR\FM\31OCN1.SGM 31OCN1 64806 Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices title ‘‘Application for Participation in the Food and Drug Administration Commissioner’s Fellowship Program.’’ Also include the FDA docket number found in brackets in the heading of this document. FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. SUPPLEMENTARY INFORMATION: Application for Participation in the FDA Commissioner’s Fellowship Program; (OMB Control Number 0910— New) Sections 1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 of Title 5 of the United States Code authorize Federal Agencies to rate applicants for Federal jobs. Collecting applications for the Commissioner’s Fellowship Program will allow FDA’s Office of the Commissioner to easily and efficiently elicit and review information from students and health care professionals who are interested in becoming involved in FDA-wide activities. The process will reduce the time and cost of submitting written documentation to the Agency and lessen the likelihood of applications being misrouted within the Agency mail system. It will assist the Agency in promoting and protecting the public health by encouraging outside persons to share their expertise with FDA. In the Federal Register of August 4, 2014 (79 FR 45196), FDA published a 60-day notice requesting public comment on the proposed collection of information. Although one comment was received, it was not responsive to the four collection of information topics solicited and, therefore, will not be discussed in this document. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of respondents Activity/5 U.S.C. section Number of responses per respondent Total annual responses Average burden per response Total hours 1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 ....... 600 1 600 1.33 798 Total .............................................................................. ........................ ........................ ........................ ........................ 798 1 There are no capital costs or operating and maintenance costs associated with this collection of information. FDA based these estimates on the number of inquiries that have been received concerning the program and the number of requests for application forms over the past 5 years. Dated: October 27, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014–25893 Filed 10–30–14; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0801] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Exports: Notification and Recordkeeping Requirements; Correction AGENCY: Food and Drug Administration, HHS. ACTION: document announced that a proposed collection of information had been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. In this document, we correct some errors that appeared in the notice. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. In FR Doc. 2014–24293, appearing on page 61643 in the Federal Register of October 14, 2014 (79 FR 61643), we make the following correction: On page 61644, replace table 1 with the following table: SUPPLEMENTARY INFORMATION: Notice; correction. The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of October 14, 2014. The SUMMARY: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of respondents asabaliauskas on DSK5VPTVN1PROD with NOTICES 21 CFR section Number of responses per respondent Total annual responses Average burden per response Total hours 1.101(d) (Non-Tobacco) (CBER) ......................................... 1,101(d) (Non-Tobacco) (CDER) ......................................... 1.101(d) (Non-Tobacco) (CDRH) ......................................... 5 5 63 193 180 130 965 900 8,190 15 15 15 14,475 13,500 122,850 Total 2 ............................................................................ ........................ ........................ ........................ ........................ 150,825 1 There are no capital costs or operating and maintenance costs associated with this collection of information. to a clerical error, the reporting burden for ‘‘Exports: Notification and Recordkeeping Requirements’’, which published on July 3, 2014 (79 FR 38036), was incorrect. Table 1 of this document contains the correct reporting burden for this collection. 2 Due VerDate Sep<11>2014 20:52 Oct 30, 2014 Jkt 235001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\31OCN1.SGM 31OCN1

Agencies

[Federal Register Volume 79, Number 211 (Friday, October 31, 2014)]
[Notices]
[Pages 64805-64806]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-25893]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1072]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Application for 
Participation in the Food and Drug Administration Commissioner's 
Fellowship Program

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by 
December 1, 2014.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be faxed to the Office 
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, 
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All 
comments should be identified with the OMB control number 0910--New and

[[Page 64806]]

title ``Application for Participation in the Food and Drug 
Administration Commissioner's Fellowship Program.'' Also include the 
FDA docket number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Application for Participation in the FDA Commissioner's Fellowship 
Program; (OMB Control Number 0910--New)

    Sections 1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 of 
Title 5 of the United States Code authorize Federal Agencies to rate 
applicants for Federal jobs. Collecting applications for the 
Commissioner's Fellowship Program will allow FDA's Office of the 
Commissioner to easily and efficiently elicit and review information 
from students and health care professionals who are interested in 
becoming involved in FDA-wide activities. The process will reduce the 
time and cost of submitting written documentation to the Agency and 
lessen the likelihood of applications being misrouted within the Agency 
mail system. It will assist the Agency in promoting and protecting the 
public health by encouraging outside persons to share their expertise 
with FDA.
    In the Federal Register of August 4, 2014 (79 FR 45196), FDA 
published a 60-day notice requesting public comment on the proposed 
collection of information. Although one comment was received, it was 
not responsive to the four collection of information topics solicited 
and, therefore, will not be discussed in this document.
    FDA estimates the burden of this collection of information as 
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of                        Average
    Activity/5 U.S.C. section        Number of     responses per   Total annual     burden per      Total hours
                                    respondents     respondent       responses       response
----------------------------------------------------------------------------------------------------------------
1104, 1302, 3301, 3304, 3320,                600               1             600            1.33             798
 3361, 3393, and 3394...........
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............             798
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    FDA based these estimates on the number of inquiries that have been 
received concerning the program and the number of requests for 
application forms over the past 5 years.

    Dated: October 27, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-25893 Filed 10-30-14; 8:45 am]
BILLING CODE 4164-01-P